Skip to main content

Chemical Wound Debridement Acidic Gel

Type: Contract Extension Category: Rehabilitation and Community Reference: TBC Supply Route: eDirect
Start Date: 10 October 2022 Expiry Date: 31 August 2025

The framework starts on 10 October 2022, will run for 35 months and ends on 31 August 2025. This includes a 24 month extension.

This product has not been available to the NHS previously and was highlighted through the Healthtech Connect Innovation route with NICE guidance. The product “Debrichem” is being supplied by Edge Medical Ltd who are a well-established supplier on the Orthopaedics Framework Agreement and has been awarded to a direct contract due to the uniqueness of the product.

Chemical Wound Debridement Acidic Gel is used for topical application to a chronic wound to help facilitate removal of sloughy and damaged tissue by the means of chemical debridement as an alternative to sharp debridement (the removal of damaged tissue or foreign objects from a wound), followed by standard cleaning and dressing. Disruption of the biofilm and removal of the infection in chronic wounds in up to 60 seconds. By withdrawing water-molecules from the biofilm, the desiccant gel rapidly disrupts the biofilm, pathogens and inflammatory proteins in the wound, aiming to turn chronic wounds into acute wounds. This is an acidic gel that is applied directly onto the wound bed for up to 60 seconds. It is rinsed off with sterile or saline water, after which the natural wound healing process will start.

There is one lot on this new framework:

  • Lot 1: Chemical wound debridement acidic gel

Sustainable opportunities/solutions/products on this framework

This product contains;

  • Glass recyclable vials
  • Recyclable cardboard packaging
  • No requirement for clinical waste.

Download our publications ▼

  • Product Listing Chemical Wound Debridement Acidic Gel

    An Excel file showing the product listing for Chemical Wound Debridement Acidic Gel.
    Login to view the downloads